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The still elusive structural difference of non-infectious and infectious amyloid of the mammalian prion protein (PrP)
is a major pending milestone in understanding protein-mediated infectivity in neurodegenerative diseases.
Preparations of PrP-amyloid proven to be infectious have never been investigated with a high-resolution technique. All
available models to date have been based on low-resolution data. Here, we establish protocols for the preparation of
infectious samples of full-length recombinant (rec) PrP-amyloid in NMR-sufficient amounts by spontaneous fibrillation
and seeded fibril growth from brain extract. We link biological and structural data of infectious recPrP-amyloid, derived
from bioassays, atomic force microscopy, and solid-state NMR spectroscopy. Our data indicate a semi-mobile
N‑terminus, some residues with secondary chemical shifts typical of a‑helical secondary structure in the middle part
between »115 to »155, and a distinct b‑sheet core C‑terminal of residue »155. These findings are not in agreement
with all current models for PrP-amyloid. We also provide evidence that samples seeded from brain extract may not
differ in the overall arrangement of secondary structure elements, but rather in the flexibility of protein segments
outside the b-core region. Taken together, our protocols provide an essential basis for the high-resolution
characterization of non-infectious and infectious PrP-amyloid in the near future.
Introduction
Prion diseases are fatal neurodegenerative disorders including
Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform
encephalopathy (BSE) in cattle, and scrapie in sheep. These dis-
orders are associated with the conformational conversion of the
cellular prion protein (PrPC) into a misfolded isoform (PrPSc),
the pathological and infectious prion agent.1 Prions are formed
via nucleation-dependent polymerization, in which pre-formed
amyloid fibrils of PrPSc act as a template for PrPC-conversion.
Infectious PrP-amyloid has also been formed spontaneously
solely from recombinant (rec) PrP.2 Differences in infectivity
titers of PrPSc and recPrP-amyloid are explained by structural dif-
ferences. X-ray diffraction spectra of recPrP-amyloids correspond
to a stack of b‑sandwiches, while X-ray diffraction spectra of
PrPSc lack a 10 nm equatorial reflection characteristic of
b‑sandwiches.3 Whereas solution-state NMR spectroscopy
was used to determine the structure of soluble PrPC 4 and to
identify segments involved in oligomerization,5 the structure of
PrP-amyloid is still elusive. Studies have so far been limited to
relatively low-resolution techniques.6-10 These studies have sug-
gested a superpleated b‑sandwich model for recPrP-fibrils charac-
terized by a parallel, in-register alignment of b‑strands within a
core domain comprising residues 160‑220.6 Alternatively, a left-
handed parallel b‑helix with the b‑sheet core between residues
89‑175 has been suggested based on EM studies on 2D-crystals
of PrP27‑30, a fragment of PrPSc resulting from proteinase K-
digestion of the »90 N‑terminal residues.11 Recent high-resolu-
tion solid-state NMR-studies of recPrP(23‑144)-fibrils suggested
a b‑strand‑turn‑b‑strand motif for the »30 C‑terminal amino
acid residues, whereas no distinct NMR resonances were
observed for the highly dynamic and disordered N‑terminus.12 A
lack of b‑strands N-terminal of position 145 in full-length
recPrP-fibrils as demonstrated by H/D exchange,13 however,
indicates that data on truncated PrP-constructs or PrP-fragments
are difficult to be extrapolated to infer the full-length PrP-struc-
ture. For full-length recPrP(23‑231)-fibrils, solid-state NMR
studies on selectively 13CO-labeled samples confirmed an
© Henrik M€uller, Oleksandr Brener, Olivier Andreoletti, Timo Piechatzek, Dieter Willbold, Giuseppe Legname, and Henrike Heise
*Correspondence to: Henrik M€uller; Email: henrik.muller@chem.ox.ac.uk; Henrike Heise; Email: h.heise@fz-juelich.de
Submitted: 06/14/2014; Revised: 07/27/2014; Accepted: 09/29/2014
http://dx.doi.org/10.4161/19336896.2014.983754
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The
moral rights of the named author(s) have been asserted.
344 Volume 8 Issue 5Prion
Prion 8:5, 344--358; September/October 2014; Published with license by Taylor & Francis
RESEARCH PAPER
in-register parallel arrangement of b‑strands.14 In light of severely
broadened lines in spectra of uniformly 13C,15N-labeled fibrils,
however, only residue types could be partially assigned to cross
peak clusters. Assignment probabilities predicted by a Monte
Carlo/simulated annealing algorithm suggested a fibril core com-
prising the 173‑224 segment but could not rule out an involvement
of the 95‑161 segment.14 Scrapie prion-seeded Syrian hamster
recPrP(90-231)-fibrils were confirmed by 1D-solid-state NMR
studies on selectively 13CO-labeled samples to have a parallel in-
register b‑sheet architecture in the C-terminal segment as well.15
Taken together, there is a need for improved protocols and
additional experimental data to discriminate among different
models for amyloid fibrils of PrP and to understand which struc-
tural features can render proteins infectious. The lack of high-reso-
lution data is not only due to the general challenge posed to
structure analysis by insoluble, non-crystalline, and heterogeneous
samples, but also to the impossibility to prepare NMR-sufficient
amounts of homogeneous brain-purified samples. However, it is
known that fibrils grown from seeds, i.e. short fibril fragments
produced by sonication of brain-purified fibrils, retain the molec-
ular structures of the seeds.16-18 Consequently, seeded fibril
growth can be exploited to amplify and label structures present in
brain tissue.15,19,20 Likewise, different strains of the yeast prion
Sup35p were faithfully passed on to recombinantly expressed
Sup35p monomers by seeding with yeast cell lysates.21
In contrast to all other amyloid fibrils, in vitro-generated PrP-
amyloid offers the crucial advantage that its physiological rele-
vance to neurodegenerative diseases in mammals can be assessed
directly. Only when in vitro-generated PrP-amyloid proves to be
infectious in animals, it is relevant in vivo. Up to now, PrP-amy-
loid, proven to be infectious, has never been investigated with a
high-resolution technique. Moreover, data of infectious samples
are restricted to laboratory animals such as mouse and hamster.
Species that are important from a veterinary point of view, such
as cattle or sheep, have never been investigated.
Here, we demonstrate methodologies for reproducibly prepar-
ing infectious samples containing sheep full-length recPrP(25-
233)-amyloid. Ovine recPrP(25‑233)-amyloid was formed by
spontaneous conversion and by nucleation with scrapie brain
seeds in high yield and purity. For the first time, we have inves-
tigated the biologically authentic system of amyloid fibrils of
full-length recPrP (recPrP-amyloid) by a multidisciplinary com-
bination of bioassays and biophysical characterization with
solid-state NMR spectroscopy. Our present data are consistent
with a b‑sheet core C‑terminal of residues »155 and a partially
a‑helical middle segment between residues »115–155. Since
NMR spectroscopy of our recPrP-amyloid samples investigates
not only single molecules within the sample but the complete
ensemble of all conformations present in oligomeric and fibrillar
states, our data allow us to verify structural models for the
dominating conformation. In addition, our data indicate that
recPrP-amyloid after seeding with brain extracts may differ in
the flexibility of the partially a‑helical middle segment. Based
on our established protocols, a high-resolution characterization
of infectious PrP-amyloid appears to be tangible in the near
future.
Results
Concept of the study
We investigated infectious samples of ovine (ov) ARQ full-
length recombinant (rec) PrP(25‑233)-amyloid for several rea-
sons: (i) Only full-length recPrP (see Fig. S1) encompasses the
entire brain PrPSc sequence containing all prion disease-related
polymorphism sites. Only fibrils from full-length PrP closely
resemble structures formed in vivo.13 (ii) Scrapie is the biochemi-
cally most investigated as well as the most widespread prion dis-
ease. (iii) The well-defined set of sheep PrP-polymorphisms at
positions 136 (A/V), 154 (R/H), and 171 (Q/R/H) governs
scrapie susceptibility and allows further study of structure-
infectivity relationships. The homozygous combination
A136R154Q171 is associated with highest scrapie susceptibility and
frequency.22 (iv) RecPrP-fibrils can be generated either under
partially denaturing conditions 2 or by protein misfolding cyclic
amplification (PMCA).23,24 Although PMCA generates highly
infectious recPrP-samples, if only in some batches, its usefulness
for NMR studies is limited because PMCA sonication introduces
a high well-to-well variability in recPrPSc-yield. A gravely poly-
morphic mixture is the undesirable PMCA outcome.25-27 This
lack of homogeneity poses an insurmountable obstacle for latest
state of the art solid-state NMR-spectroscopy of a 209-residue
protein such as PrP. In contrast, uniform protein denaturation
by guanidinhydrochloride (GdnHCl) and urea results in less
infectious but homogeneous recPrP-samples (recPrP-amyloid).
The less infectious character of recPrP-amyloid is explained by
structural differences to brain-derived PrPSc 3.
Generation of NMR-sufficient amounts of ovrecPrP-amyloid
Reproducible fibrillation conditions were established in 96‑well
plates for spontaneous conversion of ovrecPrP(25‑233). In a sec-
ond approach, ovrecPrP(25‑233) was seeded with sequence-identi-
cal full-length PrPSc purified from scrapie sheep brain by PTA-
precipitation (see Materials and Methods). PrPSc-seeded growth
took place days before spontaneous conversion (Fig. 1A). In light
of this considerable difference in lag phases, PrPSc-seeded and
spontaneous samples could be produced and analyzed indepen-
dently of each other. Furthermore, this confirms that the fibrilla-
tion kinetics is dominated by a seeding reaction and not by
spontaneous conversion. PTA-precipitation is not specific for
PrPSc though. Therefore, normal sheep brain was subjected to the
identical purification protocol and PTA-precipitated material
(lacking PrPSc) was used as seed. A lack of any ThT-fluorescence
increase, even after prolonged incubation times, confirmed that
recPrP-fibrillation kinetics is dominated by propagation of specific
seeds, namely PrPSc (Fig. 1A). To further reduce the risk of gener-
ating polymorphic amyloid mixtures by pooling 96‑well plates,
optimal conditions were scaled up to volumes of up to 10 ml
(Fig. 1B). Differential ultracentrifugation of samples from the
fibrillation end point followed by densitometric quantification of
Western blots indicated that about 95 % of ovrecPrP was always
converted to a fibrillar form. In summary, NMR-sufficient fibrillar
yields of 10 mg of both spontaneously generated and PrPSc-seeded
ovrecPrP-amyloid could be prepared in 10 ml volumes each.
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Infectivity
Aliquots of 13C,15N-ARQ-ovrecPrP(25‑233)-samples were
inoculated in transgenic mice, homozygously overexpressing
ovine VRQ- or ARQ PrP(25‑233), respectively. Non-fibrillated
ovrecPrP(25‑233) failed to induce noticeable prion disease symp-
toms in any mouse even 630 days after inoculation (Table 1),
disproving a prion disease-inducing effect of the stress during
sample injection. In contrast, 3 out of 12 mice inoculated with
spontaneously fibrillated ovrecPrP (in the absence of seeding
with PrPSc) succumbed to a prion disease, confirming the infec-
tious character of our non-seeded samples. Because less than
100 % of mice developed a prion disease, the infectious titer can
be considered to be lower than 102 ID50/ml.
28 According to
literature, the onset of neurological dysfunction in Syrian Gold
hamsters or transgenic mice takes place between 380 and
750 days after inoculation of spontaneously generated recPrP-
amyloid.29-31 Although our incubation periods are at the shorter
end of this range, their high standard deviation also indicates the
presence of low infectivity titers. Whether our relatively short
incubation periods are a feature of the details of our preparation
conditions, the ovine recPrP-sequence, or the associated confor-
mational stability remains uncertain.29-31 After inoculation of
the brain homogenates of these diseased mice into the same
mouse line, 100 % of mice developed a prion disease with incu-
bation periods characteristic for high prion infectivity. The incu-
bation periods in transgenic ARQ mice even indicate prion
infectivity as high as in brain-derived PrPSc (see Table 1). Small
standard deviations in incubation periods also indicate a highly
efficient transmission. Taken together, these findings confirm the
infectious character of our non-seeded samples. After one passage
our low infectivity recPrP-amyloid was transformed into highly
infectious PrPSc.32 It is also noteworthy that the incubation peri-
ods observed in these second passages differ from incubation
periods of PrPSc-seeds and PrPSc-seeded ovrecPrP-amyloid (see
below). This makes a contamination of spontaneously generated
ovrecPrP-amyloid with PrPSc-seeds highly unlikely.
In order to confirm the presence of PrPSc in mice, brain
extracts were analyzed for partial proteinase K (PK)-resistance
which is the biochemical marker in routine prion tests.33 A par-
tial PK-resistance is evident from a molecular weight shift of the
di-, mono-, and unglycosylated PrP‑forms caused by the diges-
tion of about 70 N‑terminal residues. All mice inoculated with
non-fibrillated ovrecPrP(25‑233) failed to show any PK-resistant
PrPSc (Fig. 2A). Although samples of spontaneously fibrillated
ovrecPrP(25‑233) used for inoculation did not show any PK-
resistance either (Fig. 2B), the 3 partially PK-resistant
PrPSc‑forms were present in brain extracts of all symptomatical
mice (Fig. 2A), confirming prion diseases.
In contrast to spontaneously generated recPrP-amyloid,
PrPSc-seeded samples induced prion diseases in 100 % of the
inoculated mice at the first passage (Table 1). It is well known
that animals inoculated with in vitro-propagated PrPSc exhibit an
altered relationship between incubation period and infectivity
titer 25. A comparison with the incubation periods induced by
brain-derived PrPSc (Table 1) is thus not valid. Samples of PrPSc-
seeded ovrecPrP(25‑233) before inoculation also did not show
any PK-resistance (Fig. 2D).
It was beyond the scope of this manuscript to determine
whether infectivity is associated with ovrecPrP-fibrils or pre-
fibrillar aggregates. Solid-state NMR spectroscopy, however,
allowed us to investigate the complete ensemble of conformations
present after ovrecPrP-conversion. Measured line widths indicate
structurally very similar conformations (see below).
Secondary and ultrastructural properties
A circular dichroism (CD) spectrum of the fibrillation starting
point, i.e., monomeric ovrecPrP(25‑233), is indicative of low
b‑sheet content as known for both PrPC and natively refolded
recPrP.33 Satisfactory CD spectra of recPrP-amyloid were only
A
B
Figure 1. ThT fluorescence detection of amyloid formation during spon-
taneous and PrPSc-seeded fibrillation. (A) Amyloid formation of 100 ng
ml‑1 ovrecPrP(25‑233) in volumes of 150 ml was analyzed in 96-well
plates in absence or presence of PrPSc-seeds obtained by PTA-precipita-
tion of scrapie sheep brain homogenate. As controls for PrPSc-seeded
fibrillation, PTA-precipitated scrapie sheep brain homogenate in absence
of ovrecPrP(25-233) (PrPSc seed only) and PTA-precipitated normal sheep
brain homogenate in presence of ovrecPrP(25-233) (neg. seed C recPrP)
demonstrate the specificity of the fibrillation assay. (B) Amyloid forma-
tion of 1000 ng ml¡1 ovrecPrP(25‑233) in NMR-sufficient volumes of
10 ml was analyzed. Note that seeded fibril growth (PrPSc seed C recPrP)
is completed before spontaneous conversion (recPrP only) starts. The
decrease in ThT-fluorescence intensity after long times is attributed to
lateral fibril association and blockage of ThT-binding sites. Values shown
are means § standard errors for up to 10 distinct experiments. The grad-
ually increasing error bars reflect the fibril size distribution in a heteroge-
neous system.
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obtained after gentle sonication in presence of small concentra-
tions of SDS. This mild treatment does not influence the second-
ary structure of recPrP-amyloid (see Materials and Methods for
details) but allows for CD-analysis. OvrecPrP-conformations
after spontaneous conversion or PrPSc-seeding combine a
b-sheet structure with additional a‑helical/random coil segments
and are thus completely different from natively folded mono-
meric ovrecPrP(25‑233) (Fig. 3). Although CD spectra after
spontaneous conversion or PrPSc-seeding are characterized by
identical minima, zero crossings, and maxima, the measured
mean residue molar ellipticities of both
sample types differ considerably. The
higher mean residue molar ellipticity
intensities (which are values normalized
by the respective protein concentration)
after PrPSc-seeding indicate an increased
proportion of ovrecPrP-amyloid ame-
nable to CD analysis.
AFM analysis demonstrated that
spontaneously generated and PrPSc-
seeded ovrecPrP-fibrils substantially dif-
fer in morphology, but each fibril type
is morphologically homogeneous. After
spontaneous fibrillation (Fig. 4A), we
observed short amyloid fibrils similar to
so-called prion rods. Prion rods are
purified from infectious brain material
using detergents and limited proteolytic
digestion.34 Our short fibrils are in
agreement with the literature9,35 as they
appear straight, up to 400 nm long,
between 5 and 20 nm high, and exhibit
a strong tendency to associate into
higher order aggregates. OvrecPrP-
fibrils longer than 400 nm or twisted
fibrils were never observed, even when
pre-formed fibrils were used for seeded
fibrillation. Pre-fibrillar aggregates were
never observed either. The histogram in
Figure 4C showing the fibril widths dis-
tribution illustrates that the fibril spe-
cies have an average width of 30 §
11 nm, which is identical to literature
values.9 In contrast, ovine PrPSc-fibrils
Table 1. Incubation periods of in vitro-fibrillated ovrecPrP(25‑233) and PrPSc purified from scrapie-infected sheep brains
Inoculum Host mice No. infected/ No. inoculated Mean incubation period § SD[days]
ovrecPrP(25-233) after
spontaneous fibrillation
(in absence of any PrPScseeds)
1. passage
2. passage
tg338 (VRQ)
tgshpXI (ARQ)
tg338 (VRQ)
tgshpXI (ARQ)
1/6
2/6
6/6
6/6
507
388§ 84
253§ 4
193§ 3
ovrecPrP(25-233) after
PrPSc-seeded fibrillation
tg338 (VRQ)
tgshpXI (ARQ)
6/6
6/6
249§ 51
267§ 9
purified PrPSc-seeds tg338 (VRQ) 6/6 177 § 16
tgshpXI (ARQ) 6/6 211 § 23
monomeric ovrecPrP(25‑233) tg338 (VRQ) 0/6 —
tgshpXI (ARQ) 0/6a —
aTwo mice were found dead after 297 and 384 days, respectively, but lacked clinical signs and PK-resistant PrP27‑30.
Figure 2. Immunoblots of samples inoculated into transgenic mice and of brain material from trans-
genic mice. (A) PrPSc in brains of tgshpXI (ARQ) and tg338 (VRQ) mice, inoculated with scrapie PrPSc,
after spontaneous fibrillation of ovrecPrP(25‑233) (SP), or with non-fibrillated ovrecPrP(25‑233) (NON),
respectively, with (C) or without (¡) digestion with 50 mg/ml PK for 2 h at 37C. Only mice inoculated
with fibrillated ovrecPrP(25‑233) show PK-resistant PrP27‑30 identical to scrapie PrP27‑30. (B) Sponta-
neously fibrillated ovrecPrP(25‑233) after digestion with increasing concentrations of PK for 1 h at
37C does not show any PK-resistance. (C) For comparison, PrPSc-seeds are depicted as characterized
by a partial PK-resistance even at high PK-concentrations. (D) PrPSc-seeded ovrecPrP(25‑233) after
digestion with increasing concentrations of PK for 1 h at 37C does not show any PK-resistance. In
light of the 300-fold excess of ovrecPrP(25‑233) during seeded fibrillation (see Materials and Methods
for details), the undigested PrPSc-specific bands are too weak to show any PK-resistance after diges-
tion. Any atypical PrP-bands were not observed. Apparent molecular masses based on migration of
protein standards are indicated in kDa.
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(Fig. 4E) are characterized by lengths of several mm and a far
wider width distribution resulting in an average width of 56§
31 nm. The presence of such long PrPSc-fibrils is reminiscent of
full-length PrPSc in living cells which was observed by light,
atomic force, and scanning electron microscopy to form thin,
5 mm-long structures on the cell surface.36,37 Regarding the
average width of PrPSc-fibrils, their appearance in our AFM
images was obscured by co-purified brain matter in the form of
extraneous non-fibrillar material. Also the natural presence of
GPI-anchor and un-, mono, and diglycosylated PrPSc forms
obscured the underlying proteinaceous parts of PrPSc-fibrils caus-
ing high width standard deviations. When ovrecPrP-amyloid was
grown in presence of PrPSc-seeds [<0.5 % (vol/vol)], the result-
ing amyloid fibrils combined the PrPSc-like curvature and the
length of several mm with an average fibrillar width of 25§
13 nm (Fig. 4B and D). In contrast to spontaneous preparations,
short fibrils were never observed. Spontaneously generated and
PrPSc-seeded ovrecPrP-fibrils have different lengths but indis-
cernible average fibrillar widths. The narrowest fibrillar structures
were observed to be 6 to 8 nm in width, which is in agreement
with diameters for single PrP-filaments as determined by negative
stain EM (4.8 to 5.7 nm for PrP27‑30, 7.6 to 7.9 nm for recPrP
(90-231)-fibrils).3 Taken together, spontaneously generated
ovrecPrP-fibrils differ morphologically from brain-purified PrPSc
and PrPSc-seeded ovrecPrP-fibrils.
Absence of strongly mobile segments
NMR spectroscopy is sensitive to molecular motions on
the ms to ms timescale. It is well-known that solid-state
NMR spectra, which employ dipolar couplings for CP-excita-
tion and magnetisation transfer, often display only peaks
from a minor fraction of all residues. Only residues in rigid
segments, i.e. in the rigid amyloid core, are characterized by
strong dipolar couplings resulting in observable solid-state
NMR signals. On the other hand, highly flexible protein seg-
ments, undergoing motions in the sub-microsecond range,
may be discriminated easily from the rigid core by INEPT-
based excitation.21,38-41 In contrast to rigid and highly flexi-
ble residues though, signals from semi-flexible regions, such
as the fuzzy coat of amyloid fibrils, may be completely miss-
ing due to intermediate range molecular motion resulting in
severe line broadening and/or disappearance of sig-
nals.12,21,38,42 In order to compare the amounts of rigid and
mobile protein segments, we recorded 1D-13C-CP- and
1D-13C-INEPT-NMR spectra. CP-spectra, which selectively
detect rigid protein segments, revealed identically strong and
appropriately resolved resonances in samples after spontane-
ous conversion or PrPSc-seeding of ovrecPrP(25‑233). The
absence of any protein signal in all INEPT-spectra, even after
rehydration with 10 ml of H2O and measurement at 20
C,
indicated a lack of highly flexible residues in any protein seg-
ment. When CP-excitation was combined with a transverse
spin echo delay, leading to dipolar dephasing of magnetisa-
tion in rigid protein segments, all signals disappeared already
after delays as short as 300 ms. In 2D-spectra, obtained by
direct 13C-excitation followed by 100 ms PDSD-mixing, no
additional cross peaks were visible, confirming that all NMR-
visible residues had been observed in the spectra obtained
with CP excitation. Taken together, all segments in
ovrecPrP-conformers after spontaneous conversion or PrPSc-
seeding are rigid on a sub-microsecond timescale.
Homogeneity of samples
In order to identify spin systems visible in solid-state NMR
spectra, we recorded sets of 2D-(13C‑13C)- and (15N‑13C)-cor-
relation experiments (see Materials and Methods) at 0C.
Essentially identical spectra were obtained for 2 independently
prepared samples, thus indicating the reproducibility of the
experiments. In Figure 5, 2D-(13C-13C)- and (15N-13C)-spec-
tra are depicted exemplarily. Solid-state NMR spectroscopy
investigates the complete ensemble of conformations present
in pre-fibrillar and fibrillar states. 13C-line widths of isolated
cross peaks of about 120 Hz thus indicate that all conforma-
tions present in our samples, be they infectious or non-infec-
tious, need to be structurally very similar. A conformational
ensemble comprising a continuous distribution of slightly
varying conformations cannot be completely excluded though.
We did neither observe any peak doubling nor find any other
indication for the presence of completely different
conformations.
Despite careful control of sophisticated fibrillation condi-
tions in one tube per sample and 13C and 15N line widths
for resolved peaks of about 120 Hz and 450 Hz, respectively,
average line widths could not be reduced further. Neither did
hydration by addition of 10 ml H2O nor measurements at
higher temperatures up to 20C increase the spectral resolu-
tion. Also, 2 times seeding with seeds prepared from sponta-
neously generated ovrecPrP-amyloid did not render the
conformational ensemble more homogeneous. Seeding with
Figure 3. Secondary structural properties. As revealed by CD-spectros-
copy, the secondary structural transition of monomeric ovrecPrP(25 233)
due to spontaneous and PrPSc-seeded fibrillation results in spectral min-
ima at 218 nm typical for b-sheets. Zero crossings at 204 nm and spec-
tral maxima at 193 nm are probable to indicate additional a-helical/
random coil elements. For comparison, a spectrum of a‑helical mono-
meric ovrecPrP(25-233) is also presented. All given values are mean resi-
due molar ellipticities ([u]MRW).
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PrPSc, however, did result
in samples whose 2D-cor-
relation spectra exhibit
both reduced intensities
and absence of some
cross peaks (see below).
Assignment process
In light of the spectral
overlap, particularly in
highly populated chemical
shift regions (e.g. at
55 ppm £ 35 ppm or
30 ppm £ 25 ppm in
Figure 5A), the challenge
of obtaining residue type-
specific assignments could
only be met by comparing
peak maxima in a given
spectrum with the com-
plete set of all other homo-
nuclear and heteronuclear
2D-spectra. A cross peak
was only regarded to be
genuine and residue type-
specific, when (i) it was vis-
ible using different apod-
isation functions, (ii) a
clear peak was visible in
the corresponding 1D-
traces, and most impor-
tantly (iii) cross peaks at
corresponding chemical
shifts were observed in all
other correlation spectra.
Using these stringent crite-
ria, we could differentiate
among distinct spin sys-
tems of nearly every amino
acid type. For most of the
amino acid types, however,
we do not observe sepa-
rated cross peaks indicative
of different residues but
clusters of merging cross
peaks with a width of sev-
eral hundred Hz. This is
depicted exemplarily in
Figure S2 for the threonine
and asparagine regions of
2D-(13C-13C)-spectra.
Only by comparing
peak maxima in a given
spectrum with the com-
plete set of all other
A B
C D
E
Figure 4. Ultrastructural properties. Low magnification amplitude AFM-images (A and B) and corresponding
fibril width distributions (C and D) obtained after (A and C) spontaneous or (B and D) PrPSc-seeded fibrillation of
ovrecPrP(25-233) display variability in fibrillar topology. The black curves in (C and D) are fits with a Gaussian function
illustrating that spontaneous and PrPSc-seeded ovrecPrP-fibrils have identical average widths within the margin of
error. However, spontaneously generated ovrecPrP-fibrils have only a length of up 400 nm (A), whereas PrPSc-fibrils
in scrapie-infected sheep brain homogenate (E) and PrPSc-seeded fibrils (B) are several mm long. In (A), an inset of
higher magnification shows the morphology of spontaneously generated ovrecPrP-fibrils to higher details. Immedi-
ately before AFM-measurement, all samples were subjected to mild sonication for 10 sec. Thus, (E) depicts PrPSc-fibrils
as they were used for seeding of ovrecPrP(25‑233).
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homonuclear and hetero-
nuclear spectra, peaks
within the cross peak clus-
ters could be assigned to
different residues. This is
demonstrated exemplary in
Figures S3–S5 for the
identification of alanine,
leucine, and glycine spin
systems. Alanine cross
peaks, for example, could
only be distinguished using
the N‑Cb-correlations
resolved nicely in
NCACB-type spectra
(Fig. S3F). However,
NMR assignments are only
considered to be trustwor-
thy, when there is just one
assignment per separated
cross peak. As more resi-
dues do contribute to the
observed signals, Tables S1
and S2 summarize only a
reduced set of average
chemical shifts. These cor-
respond to sub-clusters of
cross peaks and stand up to
close scrutiny. E.g. for
threonine and asparagine
residues, only 4 and 3
assignments are given,
respectively, although the
combination of informa-
tion of all homonuclear
and heteronuclear spectra
indicates the presence
of more residues (see
Fig. S2). Consequently,
the numbers of given
assignments (59 after
PrPSc-seeded conversion
and 73 after spontaneous
conversion, respectively)
are a lower estimate of visi-
ble residues. Standard devi-
ations and numbers of
assignments are provided
in Tables S1 and S2 as a
measure for the accuracy of
our chemical shifts.
Sequence specific assign-
ments can in principle be obtained by linking NCACX-cross
peaks of individual residues via backbone 15N chemical shifts
with NCOCX-cross peaks of the preceding residue in the amino
acid sequence. Our heteronuclear spectra (see e.g., Fig. 5B),
however, suffer from severe spectral overlap in the 15N-dimension.
Since several residue-type assignments are conceivable for nearly
every cross peak in (15N-13C)-correlation spectra (except alanine
and threonine N‑Cb- and glycine N‑Ca-cross peaks), no
A
B
Figure 5. 2D-(13C‑13C)- and (15N‑13C)-solid-state NMR correlation spectra. For identification of spin systems, homo-
and heteronuclear correlation spectra were analyzed jointly. The aliphatic regions of (A) (13C‑13C)- and (B) (15N‑13C)-
correlation spectra after spontaneous fibrillation of ovrecPrP(25‑233) are depicted, acquired with (A) PDSD-mixing for
20 ms at 11 kHz MAS and (B) DREAM-mixing at 23 kHz MAS, to obtain intraresidue correlations. All cross peaks are
labeled according to Tables S1, S2, and S3. Note that in (B) several tentative assignments are present more than
one time, reflecting the ambiguity as summarized in Table S3.
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unambiguous sequential assignments could be obtained yet.
Table S3 summarizes all possible residue type–specific 15N-assign-
ments. To improve resolution and thereby allow for sequential
assignments, heteronuclear 3D-spectra of selectively labeled sam-
ples are necessary. This analysis is currently underway in our labo-
ratory but is beyond the scope of this manuscript.
Secondary structure distribution, comparison of amyloid
types, and flexibility
In contrast to earlier studies of recPrP-samples, our solid-state
NMR-data of infectious recPrP-amyloid allow us to draw the fol-
lowing conclusions:
(i) The secondary chemical shifts of ovrecPrP(25‑233) after
spontaneous conversion or PrPSc-seeding are similar
though not identical (Fig. 6), indicating similar underlying
conformational motifs. An overlay of solid-state NMR
spectra of both preparations, however, visualises slightly
different cross peak patterns and intensities suggesting the
presence of deviating structural features. Since site-specific
information is missing, however, it cannot be decided
whether slightly different cross peak positions indicate local
structural differences only.
(ii) The number of identified residues in solid-state NMR spec-
tra is apparently smaller than the number of amino acid res-
idues in the ovrecPrP(25‑233)-sequence. This is mainly
due to a severe spectral overlap, particularly in highly popu-
lated chemical shift regions. The numbers given in Tables
S1 and S2 are a lower limit of visible residues because it is
highly probable that more residues contribute to overlap-
ping cross peaks. In addition, we cannot exclude that line
broadening effects further reduce the number of identifi-
able residues. The complete lack of INEPT-signals (see
above) confirms that all segments in ovrecPrP-conformers
after spontaneous conversion or PrPSc-seeding are rigid on
a sub-microsecond time scale. Apart from spectral overlap,
a smaller than expected number of rigid residues may addi-
tionally be due to exchange broadening by molecular
motions on the NMR-time scale or due to extensive inho-
mogeneous line broadening beyond detectability as a result
of a high degree of disorder in completely rigid segments.
(iii) The segment C‑terminal of sequence position 100 contains
only 10 out of 43 glycine residues. We observed, however,
the up to twofold number of glycine cross peaks (see
Fig. S5). A number of 10 glycine residues represent only
7.5 % of all 133 residues C‑terminal of sequence position
100. The integrals of the glycine-specific N‑Ca-region in
2D-(15N‑13Ca)-spectra (without any following mixing)
and the glycine-specific CO‑Ca-region in 2D-(13C‑13C)-
correlation spectra, however, constitute on average 14.6 §
1.5 % of the entire Ca-region in the respective spectrum.
This indicates that either a small fraction of the N-terminus
does contribute to solid-state NMR-spectra or that glycine-
containing regions C‑terminal of sequence position 100 are
disordered to some extent.
(iv) The secondary chemical shifts (Fig. 6) are in agreement
with our CD measurements confirming a dominance of
residues in a b‑sheet conformation. According to FTIR-
and CD-data, PrPSc comprises 34–43 % b‑sheets, whereas
PrP27‑30, obtained by proteolytic removal of the flexible
N‑terminal PrPSc-segment, is characterized by 43–54 %
b‑sheet contents.43-45 When we differentiate our secondary
chemical shifts into the categories >1 ppm a‑helical,
<1 ppm/ >‑1 ppm random coil, and <‑1 ppm b‑sheet
content, then b‑sheet contents of 60 % (PrPSc-seeded con-
version) and 53 % (spontaneous conversion) match best
with the values for PrP27‑30. This supports the view that it
is mainly signals from a rigid C‑terminal fibril segment that
contribute to our solid-state NMR spectra. Values for
a‑helical contributions are not compared because FTIR-
and CD-based data have been criticized recently not to sup-
port the presence of residual a‑helices in PrPSc and
PrP27‑30.46
(v) A sequentially assigned minimum of 3 consecutive b‑sheet
residues or 4 consecutive a‑helical residues are required to
define a b‑strand or an a‑helix, respectively, at a distinct
sequence position.47 Although we lack site-specific assign-
ments, we found some hints for the position of secondary
structure elements by combining the secondary structure
information for individual amino acid types which infor-
mation about the primary sequence. The 3 ovrecPrP
(25‑233)-leucine residues are at positions 128, 133, and
141, i.e., clustered in the middle region. All of them are
characterized by a‑helical chemical shift signatures. Seven
out of 9 alanine residues in ovrecPrP(25‑233) are clustered
at positions 116, 118, 119, 120, 121, 123, and 136. At
least 4 alanine residues identified in our spectra have chemi-
cal shifts indicative of a‑helical secondary structure. Eight
out of 11 arginine residues in ovrecPrP(25‑233) are N‑ter-
minal of position 168. All signals assigned to arginine resi-
dues have chemical shifts indicative of a‑helical secondary
structure. These observations suggest that this middle
region of fibrillated ovrecPrP(25‑233) contains either sev-
eral closely adjacent b‑turns and/or a residual a‑helical
secondary structure. All resonances with an a‑helical chem-
ical shift signature can be assigned to this region, either
unambiguously (Leu128, Leu133, Leu141) or tentatively
Figure 6. Secondary chemical shifts. A comparison of secondary chemi-
cal shifts of ovrecPrP(25‑233) after spontaneous (black) or PrPSc-seeded
(red) conversion suggests that both amyloid types share a similar overall
arrangement of secondary structure elements. All amino acid residues
are listed in alphabetic order.
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(Ala116, Ala118, Ala119, Ala120, Ala121, Ala123, Ala136,
Asp147, Asp150, Arg139, Arg151, Arg154, His114,
His143, Gln101, Ser135, Ser138, Val124, and Val125).
(vi) All other secondary chemical shifts are indicative of amino
acid residues in a b-sheet conformation. A semi-mobile
N‑terminus and residual a‑helical segments between resi-
dues »115 and »155 imply that the majority of these
b‑strand residues are confined to the segment C-terminal
of residue »155.
(vii) Higher mean residue molar ellipticity intensities after
PrPSc-seeding indicated an increased proportion of
ovrecPrP-conformers amenable to CD analysis which
implies higher flexibility of at least some segments of PrPSc-
seeded conformations (Fig. 3). In 2D-(13C‑13C)-solid-state
NMR spectra using homonuclear transfer based on dipolar
recoupling, cross peak intensities of specific amino acid res-
idues, e.g. of proline and leucine residues, are weakened
when samples are generated by PrPSc-seeding. To account
for possibly deviating hydration states, samples were rehy-
drated by adding 10 ml of H2O each. No change in the
respective intensities or line widths of cross peaks was
observed. A comparison of identically recorded and proc-
essed 2D-(13C‑13C)-DREAM spectra of identically pre-
pared (except for the presence or absence of PrPSc-seeds
during fibrillation) 10‑mg samples of both amyloid types
confirmed an increased flexibility after PrPSc-seeding. An
overlay of the aliphatic regions of these spectra is depicted
in Figure 7A, whereas Figure 7C–E display some regions
of interest in higher magnification. DREAM spectra display
cross peaks only for correlations between directly bound
13C atoms and thus allowed for quantitative intensity anal-
ysis. Since only some cross peaks of lysine, glutamine, glu-
tamate, aspartate, histidine, isoleucine, asparagine, serine,
and tyrosine residues differed in intensity, a quantitative
conclusion could hardly be drawn for them without hetero-
nuclear 3D-spectra reducing the number of overlapping
cross peaks. However, we determined the volumes of all
Ca‑Cb‑/Cb‑Ca‑cross peaks with a‑helical or b‑sheet
chemical shift signatures, respectively, for the spectrally sep-
arated proline, valine, arginine, leucine, alanine, and threo-
nine residues.(Fig. 7B). For threonine residues (not present
between positions 115–155; 9 of 11 threonine residues are
C‑terminal of position 185), no difference in the normal-
ized cross peak intensities was observed comparing sponta-
neously generated and PrPSc-seeded samples. Cross peak
intensities of b‑sheet alanine and b‑sheet valine residues
also did not differ within an error margin of 10%. In con-
trast, all proline cross peaks almost completely vanished in
the spectra of PrPSc-seeded samples. The most C-terminal
of 15 ovrecPrP(25‑233) proline residues is located at
sequence position 168. The substantially reduced proline
intensities therefore suggest that PrPSc-seeding results in
enhanced flexibility of the N‑terminal fibril segment. The
cross peaks of a‑helical alanine, a‑helical leucine, a‑helical
arginine, and a‑helical valine residues are also considerably
weakened after PrPSc-seeding (Fig. 7). Seven of 9 alanine
residues are clustered between positions 116 and 136. All 3
leucine residues are at positions 128, 133, and 141. Eight
of 11 arginine residues are located N‑terminal of position
168. Valine residues with a‑helical chemical shift signa-
tures are believed to be located between residues 115 to
155 (see above). Taken together, only cross peak intensities
of residues N‑terminal of Pro168 seem to be affected indi-
cating again that PrPSc-seeding induces a more flexible fibril
region N-terminal of Pro168.
Discussion
Several structural models of amyloid fibrils have been pub-
lished.48,49 Recent data indicate that aberrantly folded proteins
in other neurodegenerative diseases share self-propagating infec-
tious properties similar to those in spongiform encephalopathies
caused by misfolded PrP.50,51 This emphasizes the importance of
investigating physiologically relevant conformations. Proving
that in vitro-fibrillated structures are physiologically relevant is
still a challenge though. Since no functional test is available, only
infectious samples or brain-seeded fibrils have so far been
regarded to reflect in vivo-structures.19 Earlier high-resolution
studies have never investigated samples proven to be infectious.
Here, for the first time we have linked structural and biological
data by applying a high-resolution technique to infectious sam-
ples of recPrP-amyloid from sheep, an important species from
the veterinary point of view. Our use of solid-state NMR spec-
troscopy allows for direct probing of subunit structure and
dynamics of the complete ensemble of conformations present
after conversion of ovrecPrP(25‑233). Although our data are not
high-resolution, our protocols pave the way for obtaining atomic
resolution data in the near future.
As both samples prepared either in absence or presence
of brain-purified PrPSc-seeds display similar, although not
identical, cross peak positions in solid-state NMR spectra, they
are likely to have many structural features in common. How-
ever, they differ in crucial aspects. Only after seeding of
ovrecPrP(25‑233) with brain-purified PrPSc did we observe a
morphological appearance of ovrecPrP-fibrils similar to PrPSc
(Fig. 4). Considerably shortened lag phases during seeded
ThT-assays (Fig. 1) are also in agreement with a specific propa-
gation of PrPSc. A higher proportion of ovrecPrP-conformers
amenable to CD analysis after PrPSc-seeding (Fig. 3) agrees
with an increased flexibility in PrPSc-seeded samples as sug-
gested by solid-state NMR spectra (Fig. 7). It is tempting to
speculate that these findings are in agreement with an increased
degree of disorder as known for high prion infectivity.3,52 How-
ever, as the infectivity of our PrPSc-seeded ovrecPrP-amyloid is
unknown yet (see above), we cannot derive any conclusions for
PrPSc but for infectious recPrP-amyloid.
Natively folded ovine PrPC comprises a flexible unstruc-
tured N‑terminus, 3 a‑helices Asn146‑Tyr158,
Asn174‑Thr196, and Glu203‑Tyr228, and a small b‑sheet
formed by Gly129‑Gly134 and Gln163‑Arg167.53 According
to our solid-state NMR-data, PrPSc-seeded conversion results
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Figure 7. Structure and dynamics details. Solid-state NMR comparison of ovrecPrP(25‑233) after spontaneous (black) or PrPSc-seeded (red) conversion
reveals an increased flexibility after PrPSc-seeding. (A) Overlay of 2D-(13C‑13C)-correlation spectra acquired with the identical number of transients and
increments and processed identically. DREAMmixing at 23 kHz was performed to obtain only direct correlations. Spin systems after PrPSc-seeded conver-
sion for which cross peaks are weakened up to almost completely vanished on both sides of the diagonal are indicated by arrows. (B) For intensity analy-
sis, Ca‑Cb/Cb‑Ca-peak volumes in a‑helical and b‑sheet chemical shift ranges of 2D-(13C-13C)-DREAM spectra were calculated. Peak volumes were
normalized 2-fold: (1) To account for deviating protein amounts in the samples, all values were standardized to the peak volume of the corresponding
spectrum diagonal. (2) The highest peak volume of each amino acid type (a‑helical black or b‑sheet black or a‑helical red or b‑sheet red) was set to
100 %. Note that a‑helical and b‑sheet spin systems are not present for all amino acid types. Whereas all threonines are located in b‑strands, all arginines
and leucines are characterized by a‑helical secondary structure signatures. Prolines are not known to be present in any secondary structure. Valines are
located in a‑helical as well as b‑strand conformations. (C–E) High magnification overlays of some exemplary regions of (C) leucine, (D) proline and valine,
and (E) alanine residues show that cross peak intensities for prolines (all N‑terminal of position 168), a‑helical valines, a‑helical leucines (at positions 128,
133, and 141), and a‑helical alanines (clustered between positions 116 and 136) are reduced or even completely vanished, whereas b‑strand alanines
and b‑strand valines do not display a decrease in cross peak intensities.
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in (i) a semi-rigid N‑terminus, (ii) a partially a‑helical/b‑turn
middle segment approximately between residues »115 to
»155, and (iii) a b‑sheet-core C‑terminal of residue »155.
No hints were found for an a‑helical region in the
C‑terminus.
(i) An unstructured semi-rigid N‑terminus agrees with bio-
chemical literature33 and earlier solid-state NMR studies12
of non-infectious recPrP-fibrils54 concluding that the N‑
terminus up to position 131 is not as mobile as a fully disor-
dered polypeptide in solution.
(ii) An a‑helical/b‑turn middle segment would be divided by
the a‑helix-breaking Pro140. An a‑helical segment C-ter-
minal of Pro140 may correspond to the remainder of the
PrPC a‑helix Asn146‑Tyr158. An a‑helical segment N-ter-
minal of Pro140, however, would imply a rearrangement of
the b‑strand Gly129‑Gly134 to an a‑helix upon fibrilla-
tion. Since such a conversion has never been observed, it is
doubtful whether all a‑helical chemical shift signatures
N‑terminal of Pro140 do indicate a stable a‑helical seg-
ment. At least 3 other explanations are conceivable. Firstly,
a‑helical chemical shift signatures can indicate b‑turn
motifs 55 which might adjoin to a more or less preserved
PrPC b‑strand Gly129‑Gly134. Additional b‑turn motifs
within the C‑terminal b‑sheet core cannot be excluded. Sec-
ondly, we prepared our recPrP-amyloid under denaturing
conditions. For natively unstructured proteins it is known
that transient a‑helical states can be sampled prior to transi-
tion to amyloid fibrils.56,57 Thirdly, secondary chemical
shifts in unfolded proteins were found to almost be in the
range expected for a‑helical residues.58 Whatever the struc-
ture of this middle segment is, it is incompatible with the
adoption of a uniform in-register b‑sheet structure as dem-
onstrated by 1D-solid-state NMR studies on selectively
13CO-labeled scrapie prion-seeded Syrian hamster recPrP
(90-231)-fibrils.15
(iii) A b‑sheet-core C‑terminal of »155 is consistent with the
finding that Tyr152‑Arg154 remains flexible during fibrilla-
tion, whereas Tyr165‑Arg167 is part of the rigid core.59
Although we cannot determine the precise location of
b‑strands, a b‑sheet-core C-terminal of residue »155
implies a refolding of the 2 C‑terminal PrPC a‑helices. This
location of b-strands is in agreement with that proposed for
the b‑sandwich model6,15 but not with that suggested for
the spiral model60 or the published b‑helix model.11 An
alternative b‑helix model 61 comprising the C‑terminal seg-
ment would be consistent with our solid-state NMR-data
though.
In addition to morphological influences, PrPSc-seeding
increases the flexibility of some protein regions. Although we
cannot completely exclude an increased flexibility of C‑terminal
b‑strands, our data suggest that PrPSc-seeding induces an
enhanced flexibility of the a‑helical/b‑turn-rich segments
between residues »115 to »155 (Fig. 7). This is in agreement
with the observation that PrPSc-seeded recPrP(90‑231)-fibrils
consist of subpopulations with highly accessible disordered as
well as protected ordered segments in the regions 117‑133 and
145‑168.62 Furthermore, it was demonstrated that residues
117‑119 and 140‑143 are more exposed to PK-treatment and, in
turn, more likely to be in more flexible turns or loops with expo-
sure to the fibril surface.10 It also agrees with 1D-PITHIRDS-
CT solid-state NMR-measurements demonstrating a parallel
in-register b‑sheet structure for residues Ile182, Ile184, Ile197,
Ile203 and 2 of 3 of the residues Phe140, Phe174, and Phe197,
but a more disordered structure for residues Leu125 and Leu130
in scrapie prion-seeded Syrian hamster recPrP(90-231)-fibrils.15
The presence of the segments N-terminal of position 165 is man-
datory for fibrillation,59 though it is not necessarily incorporated
in the b‑sheet core6 but rather at the fibril surface. Taken
together, we hypothesize that the flexibility of this segment might
act as a sort of “gatekeeper,” subtly influencing the b‑interface
between monomeric units within fibrils and, in turn, stability,
length, and infectivity of recPrP-amyloid.
In summary, we have established protocols for the preparation
of infectious samples of full-length ovine recPrP-amyloid in
solid-state NMR-sufficient amounts uniformly labeled with 13C
and 15N. Our biophysical and solid-state NMR characterization
of several samples is consistent with recPrP-amyloid in a single
conformation. Our previous data indicate (1) a unique structure
characteristic in line with a distinct C‑terminal b‑sheet core and
a partially a‑helical middle part as the common motif of infec-
tious ovine recPrP-amyloid; and (2) deviating flexibility of
non‑b‑core segments in different PrP-amyloid types. Our estab-
lished protocols demonstrate potential for a high-resolution
structural characterization of non-infectious and infectious prep-
arations of recPrP-amyloid by solid-state NMR spectroscopy in
the near future.
Materials and Methods
Biological safety
Prion material was handled in biosafety hoods in a BSL-3**-
laboratory. For NMR-experiments, samples were transferred into
deformable, unbreakable, and hermetically sealable polyformal-
dehyde rotor inserts that were custom-built and are NMR-silent
in the chemical shift range typical for proteins (13C signals are at
89.1 ppm and 1.0 ppm).
Fibrillation
PrP expression in Escherichia coli and purification was per-
formed as described63 and adapted to full-length ovine ARQ
recPrP (25–233). Typical yields of uniformly 13C,15N isotope-
labeled ovrecPrP(25‑233) of 10‑15 mg per liter M9 minimal
medium were achieved. In vitro-conversion was carried out in
presence of 1 M GdnHCl, 2.4 M urea, and 167 mM NaCl in
20 mM sodium acetate pH 5.0 with continuous shaking at
600 r.p.m. and 37C with 100 ng ml‑1 ovrecPrP(25‑233)
(150 ml in 96-well plates) or 1000 ng ml‑1 ovrecPrP(25‑233)
(1 ml in 1.5 ml microcentrifuge tubes or 10 ml in 15 ml conical
tubes), respectively. For seeded fibrillation, PrPSc-seeds were
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prepared by precipitating 700 ml of 10 % (vol/vol) scrapie-
infected homozygous ARQ sheep brain homogenate with sodium
phosphotungstic acid (NaPTA) adapted to ovine PrPSc 64 result-
ing in sequence-identical 30 mg-ARQ PrPSc-seeds and sonicated
for 10 sec with a Misonix sonicator 3000 at 200 W and <25C.
As a control, brain homogenate of non-infected ARQ sheep was
treated identically. At the conversion endpoint, the fibrillation
buffer including residual non-fibrillar material was removed by
differential ultracentrifugation in a TL‑100 ultracentrifuge
(Beckman Instruments) with a TLA-45 rotor for 1 h at
100,000 £ g and 4C. Each pellet was washed with sterile bid-
est. water, centrifuged for 1 h at 100,000 £ g and 4C, washed
and centrifuged again. NMR samples were dried until any solu-
tion was evaporated and immediately packed in 3.2-mm rotors
and stored at 4C.
Thioflavin T–assay
Fibrillation kinetics were monitored by thioflavin T (ThT)-
fluorescence assays in 96-well, black-bottom Nunc plates in a
microplate reader (Infinite M200 Pro, Tecan Trading AG) at
37C in 150 ml fibrillation buffer and 5 mM ThT. The record-
ing parameters were: 442 nm excitation wavelength, 475 nm-
555 nm spectral range, 2 nm step resolution, 10 nm excitation
bandwidth, 20 nm emission bandwidth, gain of 80, z-position of
18300§500 mm. For analysis, intensity integrals from 475 nm
to 555 nm were calculated.
Mouse bioassay
Fibril preparations were inoculated in ovine PrP(25‑233)
transgenic mice tgshpXI and tg338 homozygously overexpressing
the ARQ- or VRQ-allele, respectively, which are both associated
with highest scrapie susceptibility and frequency.22 Before inocu-
lation, each sample was suspended in sterile PBS pH 7.4,
quick-frozen in liquid nitrogen, and stored at ¡80C. For each
determination of mean incubation periods, 6 tgshpXI mice and
6 tg338 mice aged 6 to 8 weeks were inoculated intracerebrally
with 50 ml of a given sample, examined for clinical signs of
mouse prion disease at least twice a week, and euthenized at the
point of neurologic dysfunction. Only coded information was
displayed on mice boxes to avoid observer bias. Bioassays were
terminated 630 days after inoculation. Incubation periods were
measured as the time from inoculation to onset of clinical symp-
toms. Crude brain homogenates [10 % (w/v)] were prepared
from diseased mice inoculated with spontaneously generated
ovrecPrP(25‑233)-amyloid and used for a second passage into
the same mouse line.65 PrPSc in the brains of animals was
detected by digestion of 10 % brain homogenates with 50 mg/
ml PK (recombinant grade; Roche Applied Science) for 2 h at
37C followed by Western blot analysis.
Circular dichroism (CD) spectroscopy
Ten CD spectra per sample were collected with a Jasco J-815
spectropolarimeter at room temperature in 10 mM sodium phos-
phate pH 7.4 over the spectral range of 185 nm-260 nm at a
scan speed of 50 nm/min and a step resolution of 1 nm. Only
CD signals with a HT-value below 600 were regarded to be
reliable. Below a wavelength of 185 nm, excessive buffer absorp-
tion impeded further readings. A blank spectrum for cuvette and
buffer was subtracted from each spectrum. Satisfactory CD ellip-
ticities of recPrP-amyloid were only obtained after increasing
amyloid solubility by gentle sonication of 1 mg ml‑1 PrP in pres-
ence of 0.12 % (vol/vol) SDS with a Misonix sonicator 3000 at
240 W for 1 min at <25C.66 Neither sonication only nor SDS-
treatment only did result in measurable ellipticity. An influence
of sonication or SDS-treatment on the secondary structure of
amyloid fibrils is assumed to be negligible. A SDS-concentration
as high as 0.2 % (vol/vol) only solubilises prion fibrils.67 Prion
infectivity, which depends crucially on structural features,
remains even after boiling in 5 % SDS.68 Sonication of mono-
meric ovrecPrP(25‑233) for 45 min at 240 W changes neither
ellipticity intensity nor spectral features. Sonication for 1 min at
240 W in 0.12 % (vol/vol) SDS resulted in an increase in ellip-
ticity intensity, only accompanied by slight shifts in spectral fea-
tures of § 1nm. PTA-precipitated PrPSc was not measured
because brain homogenate impurities, glycosylations, and GPI-
anchor prevent a valid quantitative analysis.
Atomic force microscopy (AFM) and image processing
All AFM measurements were carried out with the sample
dried on the mica surface. Liquid cell AFM could not be per-
formed because of prion safety limitations, to avoid interference
of the cantilever movement with the solvent, and because a soft
coat formed in the presence of water by the disordered N-
terminal segment of PrP-fibrils may hide fibrillar topology
details.9 Immediately before AFM measurement, samples were
briefly sonicated for 10 sec with a Misonix sonicator 3000 at
200 W and <25C. Sample volumes of 40 ml containing 0.44 –
4.4 mM ovrecPrP from the fibrillation end point or PrPSc-seeds
purified from brain homogenate by precipitation with sodium
phosphotungstic acid (NaPTA) were adhered for 30 min onto a
freshly cleaved mica crystal, washed 30 times with 40 ml water
drops, and dried at room temperature for 45 min. Samples were
imaged with a NanoWizard II AFM (JPK Instruments AG)
using Olympus silicon tips on a silicon cantilever
(OMCL‑160TS‑R3) with a typical tip size of 7 nm, a spring con-
stant of 26 N m¡1, a drive frequency of 300§100 kHz, and a
scan rate of 0.5 – 1 lines sec¡1. Data were collected using inter-
mittent current AFM-mode from up to 4 different samples and
up to 3 different scanning sessions as 512 £ 512 or
1024 £ 1024 pixel images and processed using Gwyddion
software 2.22. All images were levelled by mean plane subtrac-
tion to correct for tilting of the sample stage and servo range
errors. Each scan line was corrected for streaks, scratches, and
noise related to the mica surface. Fibrillar heights were measured
perpendicular to the fibrillar axis using Gwyddion’s extract pro-
file tool, but not quantified in detail. In contrast to widths, the
heights of soft objects are usually underestimated with AFM69,70
because of the mechanical force applied, which results in elastic
deformation of polymers such as nucleic acids and protein fibrils.
Mean fibril widths and lengths were quantified at half of the max-
imal heights. Width distribution histograms were obtained by
classifying the cross section widths of >700 ovrecPrP-fibrils into
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groups of 5 nm size. To avoid measurement errors from stacked
fibrils, only isolated fibrils were considered. To account for tip
convolution, all measured widths and lengths were corrected for
the tip size.
Solid-state NMR spectroscopy
All NMR-experiments were conducted using 3.2 mm triple-
resonance (1H, 13C, 15N) probe heads at static magnetic fields of
14.1 and 18.8 T (Agilent Technologies) and MAS frequencies of
11 kHz§3 Hz or 12.5 kHz§3 Hz, respectively, for (13C, 13C)
PDSD‑71 and NCACX-/NCOCX-type spectra72 or 23.0 kHz§
5 Hz for DREAM mixing,73 respectively. Temperature was cali-
brated for each probe head and each spinning speed using nickel-
ocene.74 The cooling gas was set to a temperature that resulted in
an actual sample temperature of 0C § 2.5C. 13C and 15N
chemical shifts were referenced externally to adamantane. Typical
1H, 13C, and 15N 90 pulse lengths were 3.0 ms, 5.5 ms, and
6 ms, respectively. For heteronuclear through-bond transfer, the
INEPT scheme75 was applied. For heteronuclear through-space
transfer, chemical shift-selective (15N, 13C) and broad-band
(1H, 13C)/(1H, 15N) SPECIFIC-CP72 schemes were applied.
(13C, 13C) mixing was performed using PDSD-mixing times of
5, 10, 20, and 80 ms for intraresidue correlations or 80, 150,
and 500 ms for sequential correlations. (15N, 13C) spectra were
recorded using SPECIFIC-CP contact times between 1500 and
3500 ms followed by homonuclear PDSD-mixing of 50 to
100 ms or DREAM mixing. During indirect chemical shift evo-
lution periods and FID acquisition, 83 kHz SPINAL decou-
pling76 was applied. All spectra were recorded in form of
successive one-day data sets, which were recorded and added
until no further improvement of signal-to-noise ratios was visible.
Data sets were processed with NMRPipe77 by routinely using dif-
ferent apodisation functions, primarily shifted sine-bell squared
functions, with or without linear prediction in the indirect
dimension and analyzed with Sparky version 3.114 (T. D. God-
dard and D. G. Kneller, University of California, San Francisco).
For peak intensity analysis, square chemical shift areas were inte-
grated manually using Sparky’s sum over box integration
method. For every amino acid type, the identical chemical shift
areas were integrated 10 times, to ensure that peak volumes were
not biased by slight variations in the areas selected for integration.
Standard deviations were calculated according to [
P
(x-<)2/(n-
1)]1/2 with < the sample mean and n the sample size.
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